IGC Pharma, Inc. Research And Development Expense

• IGC Pharma, Inc. showed a decrease of -3.1% in Research And Development Expense from 2024 to 2025.
• This data is from IGC Pharma, Inc.'s annual report (Form 10-K), filed with the SEC on June 27, 2025.
• XBRL data for this metric is available from 2018 to 2025 (8 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
• Over the full 8 years of available data (2018 to 2025), IGC Pharma, Inc.'s Research And Development Expense has grown by 2,567.9%.
• Historical annual values: Fiscal year 2025: $3.66 million | Fiscal year 2024: $3.77 million | Fiscal year 2023: $3.46 million | Fiscal year 2022: $2.33 million | Fiscal year 2021: $929.0 thousand | Fiscal year 2020: $1.01 million | Fiscal year 2019: $1.26 million | Fiscal year 2018: $137.0 thousand.
• Data sourced from SEC EDGAR public filings as of June 22, 2026.

Last verified: June 22, 2026